Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The Potential of Natural Levodopa in Koro Benguk Seeds (Mucuna pruriens) for Treatment in Parkinson's Disease

View through CrossRef
Mucuna pruriens also known as velvet bean (koro benguk) is a plant commonly found in tropical regions, including Indonesia. Mucuna pruriens is known to contain high levels of Levodopa, making it a potential natural treatment for Parkinson's disease. Parkinson's disease is a neurodegenerative disorder characterized by tremors, rigidity, bradykinesia, and postural instability. The estimated global incidence of Parkinson's disease in 2024 is expected to reach 12 to 17 million patients. Synthetic Levodopa has been the standard and proven effective therapy for Parkinson's disease. The method used in the preparation of this article is a literature review by collecting relevant and focused articles. The literature sources were accessed through comprehensive searches in three databases (Pubmed, Google Scholar, and Researchgate) from 2014 to 2024, using keywords such as “Mucuna pruriens,” “Levodopa,” and “Parkinson's disease.” The result of the literature review indicates that Levodopa is the dominant active component found in Mucuna pruriens compared to other compounds. The naturally occurring Levodopa functions as a precursor to dopamine, which plays a role in the treatment of Parkinson's disease, thus it can be developed into a complementary therapy in regions with abundant resources.
Title: The Potential of Natural Levodopa in Koro Benguk Seeds (Mucuna pruriens) for Treatment in Parkinson's Disease
Description:
Mucuna pruriens also known as velvet bean (koro benguk) is a plant commonly found in tropical regions, including Indonesia.
Mucuna pruriens is known to contain high levels of Levodopa, making it a potential natural treatment for Parkinson's disease.
Parkinson's disease is a neurodegenerative disorder characterized by tremors, rigidity, bradykinesia, and postural instability.
The estimated global incidence of Parkinson's disease in 2024 is expected to reach 12 to 17 million patients.
Synthetic Levodopa has been the standard and proven effective therapy for Parkinson's disease.
The method used in the preparation of this article is a literature review by collecting relevant and focused articles.
The literature sources were accessed through comprehensive searches in three databases (Pubmed, Google Scholar, and Researchgate) from 2014 to 2024, using keywords such as “Mucuna pruriens,” “Levodopa,” and “Parkinson's disease.
” The result of the literature review indicates that Levodopa is the dominant active component found in Mucuna pruriens compared to other compounds.
The naturally occurring Levodopa functions as a precursor to dopamine, which plays a role in the treatment of Parkinson's disease, thus it can be developed into a complementary therapy in regions with abundant resources.

Related Results

Toksisitas Akut Koro Benguk (Mucuna Pruriens L.) Pada Mencit Putih Jantan
Toksisitas Akut Koro Benguk (Mucuna Pruriens L.) Pada Mencit Putih Jantan
Koro benguk merupakan tanaman pangan yang berpotensi membantu pengobatan. Koro benguk mempunyai aktivitas dapat meningkatkan antioksidan, antidiabetes dan antikanker. Data ilmiah m...
In vitro antioxidant activity of Bougainvillea glabra and Mucuna pruriens
In vitro antioxidant activity of Bougainvillea glabra and Mucuna pruriens
The purpose of the contemporary in vitro work implemented was to examine the antioxidant effect of Bougainvillea glabra and Mucuna pruriens methanol extracts. Methanol extracts of ...
Pharmacognostical, Phytochemical and Anti-Parkinson’s profile of Mucuna pruriens
Pharmacognostical, Phytochemical and Anti-Parkinson’s profile of Mucuna pruriens
Mucuna pruriens is a recognized herbal drug which contains numerous pharmacological activities. Mucuna pruriens commonly known as cow-age or cowitch or velvet bean or Alkushi. Mucu...
Review of Mucuna pruriens L. therapeutic potential for Parkinson’s disease
Review of Mucuna pruriens L. therapeutic potential for Parkinson’s disease
Parkinson’s disease is a multifactorial disorder of the nervous system, the main features of which are progressive degeneration of dopaminergic neurons in the nigra pars compacta n...
Plasma Concentration of Levodopa in Patients with Parkinson’s Disease
Plasma Concentration of Levodopa in Patients with Parkinson’s Disease
Responses in plasma concentration of levodopa to administration of levodopa alone or combined with the extracerebral decarboxylase inhibitor, Ro 4-4602, were studied in 173 parkins...
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
AbstractBackgroundLevodopa‐induced dyskinesias are an often debilitating side effect of levodopa therapy in Parkinson's disease. Although up to 90% of individuals with PD develop t...

Back to Top